Literature DB >> 10604106

Bacterial infections in liver cirrhosis.

M Navasa1, J Fernández, J Rodés.   

Abstract

The incidence of bacterial infections in cirrhotic patients admitted to hospital is very high. In several studies, 30% to 50% of cirrhotics presented bacterial infections at admission, or developed this type of complication during hospitalization. Most bacterial infections in cirrhotic patients are hospital-acquired. Between 15% to 35% of cirrhotics admitted to hospital develop nosocomial infections; these figures contrast sharply with the hospital-acquired infection rate in the general hospital population (5% to 7%). Urinary tract infections (12% to 29%), spontaneous bacterial peritonitis (7% to 23%), respiratory tract infections (6% to 10%) and bacteraemia (4% to 9%) are the most frequent bacterial infectious complications seen in cirrhotic patients. However, since spontaneous bacterial peritonitis is the most characteristic bacterial infection in cirrhosis, this report will focus (mainly) on this infectious complication.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10604106

Source DB:  PubMed          Journal:  Ital J Gastroenterol Hepatol        ISSN: 1125-8055


  20 in total

Review 1.  Gut flora and bacterial translocation in chronic liver disease.

Authors:  John Almeida; Sumedha Galhenage; Jennifer Yu; Jelica Kurtovic; Stephen M Riordan
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

Review 2.  The management of patients awaiting liver transplantation.

Authors:  Ka-Kit Li; James Neuberger
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-10-06       Impact factor: 46.802

3.  Risk factors for mortality in cirrhotic patients with sepsis.

Authors:  Lee-Guan Lim; Xiang-Xuan Eunice Tan; Shu-Jeng Woo; Yock-Young Dan; Yin-Mei Lee; Vincent Lai; Seng-Gee Lim
Journal:  Hepatol Int       Date:  2011-02-13       Impact factor: 6.047

Review 4.  Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.

Authors:  F Wong; M Bernardi; R Balk; B Christman; R Moreau; G Garcia-Tsao; D Patch; G Soriano; J Hoefs; M Navasa
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

Review 5.  Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.

Authors:  Sara Blasco-Algora; José Masegosa-Ataz; María Luisa Gutiérrez-García; Sonia Alonso-López; Conrado M Fernández-Rodríguez
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

6.  Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis.

Authors:  D Manno; M Puoti; L Signorini; G Lapadula; B Cadeo; L Soavi; G Paraninfo; R Allegri; G Cristini; P Viale; G Carosi
Journal:  Infection       Date:  2009-07-23       Impact factor: 3.553

7.  Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2.

Authors:  Alastair J O'Brien; James N Fullerton; Karen A Massey; Grace Auld; Gavin Sewell; Sarah James; Justine Newson; Effie Karra; Alison Winstanley; William Alazawi; Rita Garcia-Martinez; Joan Cordoba; Anna Nicolaou; Derek W Gilroy
Journal:  Nat Med       Date:  2014-04-13       Impact factor: 53.440

Review 8.  Cellular Abnormalities and Emerging Biomarkers in Alcohol-Associated Liver Disease.

Authors:  Ashwani K Singal; Shannon M Bailey
Journal:  Gene Expr       Date:  2018-07-25

Review 9.  Innate immune dysfunction in acute and chronic liver disease.

Authors:  Bettina Leber; Ursula Mayrhauser; Michael Rybczynski; Vanessa Stadlbauer
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 10.  Cirrhosis and its complications: evidence based treatment.

Authors:  Salman Nusrat; Muhammad S Khan; Javid Fazili; Mohammad F Madhoun
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.